Journal of Chemotherapy

7/29/2019 Journal of Chemotherapy

1/23


2/23

OPEN ACCESS: BENEFITS

Benefits to researchers, institutions, nations& Society as whole.

For researchers, increased visibility raising

impact factor. Benefit for researchers who cant pay for

paper subscription.

As in todays era of internet its free to accessresearch articles on related latest researchesto researchers & Scholars.


3/23


4/23

Chemotherapy deals with the study &

treatment of diseases using chemical

agents/drugs, that are selectively toxic to the

causative agent of the disease.


5/23

Make the research work freely accessible

globally through internet to share the

innovations of the researchers to scientific

community.

Chemotherapy aims to provide current

events, advantages and limitations in the

field of chemotherapy.


6/23

Chemotherapy: Open Access consists of

43 well qualified EB members throughout theworld mostly from USA, Japan, UK and some

other countries


7/23

EB MEMBER CATEGORISATION


8/23

JOURNAL STATUS

Started in 2011

Released first issue in March 2012Recently Released Vol. 2, Issue 3

Releasing Vol 3, Issue 1 in Feb 2013


9/23

JOURNAL STATUS


10/23

FUNDING ARTICLES

1 article funded by Japan Society for the

Promotion of Science and Smoking

Research Foundation.

Above 90% from high income country


11/23

Journal of Cancer Science & Therapy

Journal of Carcinogenesis & Mutagenesis

JCST started in 2009, Currently Vol 5, Issue 2

JCM started in 2010, Currently Vol. 3,Issue 2


12/23

RELATED JOURNALS FROM OTHER SOURCE

Journal of Chemotherapy (Maney Publishing)

Journal of Infection and Chemotherapy

(Springer)

Journal of chemotherapy (ResearchGate)

Journal of Antimicrobial Chemotherapy

(Oxford Journals)

International Journal Of Experimental &

Clinical Chemotherapy (Karger)


13/23

Two Special Issues has been approved for

Chemotherapy

Translational Pathology

Immunochemotherapy


14/23

RELATED CONFERENCES

Optimizing Outcomes in ColorectalCancer Boston, United States of America, 7thFeb 2013.

CHI's Targeting Cancer Stem Cells SanFrancisco, United States of America, 11th Feb2013.

16thScripps Cancer Center's 33rd AnnualClinical Hematology and Oncology

Conference San Diego, United States ofAmerica, 16th Feb 2013.

2nd Novel Cancer Therapeutics Summit LasVegas, United States of America, 25th Feb 2013.

24th Annual Cancer Progress Conference New


15/23

7th Conference on Experimental andTranslational Oncology -

CETO Portoroz, Slovenia, 20th April 2013.

British Gynaecological Cancer Society

Annual Scientific Meeting Belfast , Ireland,

20th June 2013.

MASCC/ISOO 2013 International Cancer

Care Symposium Berlin, Germany, 27th June2013.

27th17th ECCO - 38th ESMO - 32nd ESTRO

European Cancer th


16/23

TO ADVERTISE THE JOURNAL AT CONFERENCES

Firstly advertise on the conference website by placing banner

ads with a link to our website.

At the conference venue placing our bannersMake use of pamphlets, Journal Digital file to explain about

our journals scope.

Inviting researchers attending related conference by invitation

letter and pamphlets


17/23

INDEXING

It shows our table of content and abstracts

included in various online collections.

It increases visibility of our journal & perceived

quality of our journal.

It increases the ability to be searched for

information among various other publications.


18/23

INDEXING OF THE JOURNAL

Chemotherapy is indexed in

Google Scholar

OARE

Open J-Gate

DOAJ

COPERNICUS

SCRIUS


19/23

PLAN FOR INDEXING IN SCOPUS,MEDLINE,ISI

Issue release at regular interval.

Send invitations to quality person having

relevant field of interest as per the journal.

Coin special issue topics on recent ongoing

researches.

Updates EB profile every month based on

their designation, research interest etc.

Provide variable fee for different countries.


20/23

Gentle and polite communication in aprofessional way with the researchers.

Form your own words at different situations

or for replies instead of same type ofcommunication to gain interest fromcontributors.

Regular communication with EB membersand researchers for their suggestions andcontributors.


21/23

Updating status of EB member in websiteregarding their designation, research

interest and ongoing projects, thus by

communicating regularly to gain interest

from them.

Accepting quality paper regardless of

country.

Providing variable fee for different

countries.


22/23

CONTACT US

Articles can be submitted to

[email protected]

or

http://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.php

Website:http://www.omicsgroup.org/journals/cmthome.php
mailto:[email protected]://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.phphttp://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.phphttp://www.omicsgroup.org/journals/cmthome.phphttp://www.omicsgroup.org/journals/cmthome.phphttp://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.phphttp://omicsgroup.org/editorialtracking/chemotherapy/SubmitManuscript.phpmailto:[email protected]


23/23

Documents

Journal of Chemotherapy